The Lancet Neurology in conversation with artwork

Oral immunomodulating therapies in relapsing MS

The Lancet Neurology in conversation with

English - March 19, 2020 08:00 - 11 minutes - 7.93 MB
Life Sciences Science Education stroke alzheimer's epilepsy sleep cerebral multiple sclerosis Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The global burden of neurological conditions
Next Episode: Evidence-based support for autistic people across the lifespan

Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv